American Diversified Holdings has announced plans to spin off its GlucoGuard division into a SEPARATE PUBLICLY TRADED COMPANY — with eligible $ADHC shareholders expected to receive shares through a SPECIAL STOCK DIVIDEND.
GlucoGuard is developing a patent-pending platform designed to address dangerous nighttime hypoglycemia in diabetic patients and continues working through the FDA process.
✅ Planned GlucoGuard public-company spin-off
✅ Special stock dividend planned for eligible $ADHC shareholders
✅ Shareholders could participate in BOTH $ADHC + GlucoGuard
✅ GlucoGuard targeting a major unmet need in diabetes care
✅ Additional clinical studies planned as part of the FDA process
Keep $ADHC on the radar as this potentially major corporate catalyst develops.